Related Experiment Videos
The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs*
R H Chapman1, C P Ferrufino, S L Kowal
1US Health Economics and Outcomes Research, IMS Health, Falls Church, VA 22046, USA. RChapman@us.imshealth.com
Insights
Improving adherence to cardiovascular medications requires cost-effective interventions. This review found that while more expensive interventions like case management are more effective, simpler methods like reminders are less costly, guiding future program design.
Area of Science:
- Cardiovascular medicine
- Health economics
- Behavioral science
Background:
- Poor adherence to cardiovascular medications is a significant public health issue.
- Interventions to improve medication adherence are widely proposed but often lack comprehensive cost-effectiveness analysis.
- Understanding the relationship between intervention costs and effectiveness is crucial for optimizing patient outcomes.
Purpose of the Study:
- To review the effectiveness and associated costs of various interventions designed to improve adherence to cardiovascular disease therapies.
- To update previous reviews by incorporating recent studies on adherence interventions.
- To provide data to guide the selection and implementation of cost-effective adherence programs.
Main Methods:
- A systematic review of MEDLINE was conducted, updating a prior review with studies published between July 2002 and October 2007.
- Eligible studies compared at least one intervention against a control group, used objective adherence measures, and followed patients for at least six months.
- Effectiveness was quantified as relative improvement (RI), and costs were calculated and adjusted to 2007 US dollars for a six-month period.
Main Results:
- The review identified 23 interventions from 18 studies, with relative improvements in adherence ranging from 1.11 to 4.65.
- Six-month intervention costs varied significantly, from $10 to $142 per patient.
- Reminder interventions were least effective (RI: 1.11-1.14) but most cost-effective ($10/6 months), while case management was most effective (RI: 1.23-4.65) but most expensive ($90-$130/6 months).
Conclusions:
- A positive association generally exists between the cost of adherence interventions and their effectiveness.
- The findings suggest that a balance between cost and effectiveness should guide the design and implementation of cardiovascular medication adherence programs.
- Considering both the benefits to adherence and the associated costs is essential for developing successful interventions.
Aims:
Adherence to cardiovascular medications is poor. Accordingly, interventions have been proposed to improve adherence. However, as intervention-associated costs are rarely considered in full, we sought to review the effectiveness and costs associated with different adherence-improving interventions for cardiovascular disease therapies.
Methods:
We reviewed MEDLINE to update a prior review of interventions to improve adherence with antihypertensive and/or lipid-lowering therapy covering January 1972 to June 2002, to add studies published from July 2002 to October 2007. Eligible studies evaluated > or = 1 intervention compared with a control, used measures other than self-report, reported significant improvement in adherence and followed patients for > or = 6 months. Effectiveness was measured as relative improvement (RI), the ratio of adherence in the intervention group to the control group. Costs were calculated based on those reported in the analysis, if available or estimated based on resource use described. All costs were truncated to 6 months and adjusted to 2007 US$.
Results:
Of 755 new articles, five met all eligibility criteria. Combining with the prior review gave 23 interventions from 18 studies. RI in adherence ranged from 1.11 to 4.65. Six-month intervention costs ranged from $10 to $142 per patient. Reminders had the lowest effectiveness (RI: 1.11-1.14), but were least costly ($10/6 months). Case management was most effective (RI: 1.23-4.65), but the most costly ($90-$130/6 months).
Conclusions:
Generally, we found a positive association between intervention costs and effectiveness. Therefore, consideration of intervention costs, along with the benefits afforded to adherence, may help guide the design and implementation of adherence-improving programs.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hypertension IV: Drug Therapy and Lifestyle Modifications
Drug Therapy
Antianxiety Medications
Bioavailability Enhancement: Drug Permeability Enhancement
Hypertension V: Nursing Management